The duration of treatment ranged from 2 to 6 months
In clinical trials, people taking semaglutide lost an average of 15% in a little over a year (even more for those taking Wegovy HD), while those on tirzepatide lost an average of 21% in roughly the same time
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist , originally developed by the Danish pharmaceutical company Novo Nordisk
10.3390/genes12071096 55 NaumannH
Nutrient deficiencies in particular can be caused by malabsorption issues, bacterial overgrowth ( SIBO , Candida ), slow gut motility, diet, toxin exposures, etc
Any other antioxidant supplements in your stack (NAC, alpha-lipoic acid, vitamin C) that may compound the pharmacodynamic picture